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Abstract Dipeptidyl peptidase IV (DPP IV, CD 26) is an
integral membrane serine protease exhibiting a well character-
ized exopeptidase activity. The present study shows that DPP IV
also possesses a novel gelatinase activity and therefore endo-
peptidase activity, which was directly demonstrated by gelatin
zymography. Protease inhibitor profile analysis showed that the
endo- and exopeptidase activities of DPP IV share a common
active site. Substrate specificity was detected for denatured
collagen types I, II, III and V suggesting that DPP IV might
contribute to collagen trimming and metabolism. On the basis of
these data we propose that DPP IV and the recently sequenced
gelatinolytic seprase (FAPK) represent a new subfamily of
gelatinolytic integral membrane serine proteases.
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1. Introduction
Dipeptidyl peptidase IV (DPP IV, CD 26) is a non-classical
serine protease localized as a homodimeric integral glycopro-
tein at the cell surface of many solid tissues and di¡erent
subtypes of lymphocytes in mammals [1,2]. The amino acid
sequence [3] of the 110 kDa monomer reveals three domains.
In addition to a short intracellular N-terminal domain and the
transmembrane domain, DPP IV also contains a large extra-
cellular domain consisting of a glycosylation-rich region, a
cysteine-rich region and a region including the active site.
DPP IV has a well characterized exopeptidase activity, which
cleaves N-terminal dipeptides from bioactive peptides in
which proline is the penultimate amino acid. Peptides in which
alanine or hydroxyproline are the penultimate amino acids are
also attacked, but at a signi¢cantly lower rate. In addition to
its exopeptidase activity, Kenny et al. and Lojda et al. re-
ported that DPP IV also possesses signi¢cant endopeptidase
activity, and is able to hydrolyze certain synthetic N-terminal
blocked peptides at the carboxyl site of proline [4,5]. How-
ever, this observed endopeptidase activity could not be con-
¢rmed by other groups [6] and is possibly due to contamina-
tion with copuri¢ed prolyl endopeptidase [7].
The physiological signi¢cance of DPP IV in vertebrates is
not yet clear, although numerous possible substrates of DPP
IV have been proposed, including substance P, L-casomor-
phine, kentsin, somatoliberin and the ¢brin K-chain [8]. Ever
since the discovery of DPP IV by Hopsu-Havu and Glenner
[9], workers have suggested a role of DPP IV in collagen
metabolism, because the numerous Gly-Pro sequences in col-
lagen represent potential cleavage sites for a proline-speci¢c
hydrolase like DPP IV [10^17]. This hypothesis is supported
by the following studies. First, it has been demonstrated by
immunohistochemistry, catalytic histochemistry and a⁄nity
chromatography that DPP IV binds to collagen [13]. Second,
several groups have produced evidence for the involvement of
DPP IV in cell-matrix interaction [12,13,15,18^21]. In partic-
ular, Hanski et al. showed that the DPP IV substrate tripep-
tide Gly-Pro-Ala interferes in vitro with the initial spreading
of rat hepatocytes on both a native collagen matrix and a
denatured collagen-¢bronectin matrix [12,13]. Third, DPP
IV-negative Fischer rats were found to excrete signi¢cantly
elevated quantities of proline- and hydroxyproline-containing
peptides in their urine compared with control rats, indicating
impaired collagen metabolism in these DPP IV-negative rats
[14,22]. Fourth, amino acid sequence analysis of seprase
(FAPa), an integral membrane serine protease with signi¢cant
gelatinolytic activity, revealed remarkable structural similar-
ities to DPP IV and 68% amino acid sequence identity in the
carboxyl terminus containing the catalytic region [23]. Finally,
in a recent study we observed a release of collagen from col-
lagen-coated cover slips by liposomes containing DPP IV [17].
In summary, all these studies suggest that DPP IV may cleave
collagen. However, no direct evidence to support this hypoth-
esis has hitherto been obtained.
In the present study, we systematically investigated the abil-
ity of DPP IV to cleave collagen. We established a gelatin
zymography assay which unequivocally demonstrates a gela-
tinase and therefore endopeptidase activity of immunopuri¢ed
DPP IV. In addition, we performed soluble proteolytic assays
to characterize the active site and the substrate speci¢city of
DPP IV endopeptidase activity.
2. Materials and methods
2.1. Puri¢cation of DPP IV
DPP IV was puri¢ed from a 1% (w/v) Triton X-100 detergent ex-
tract of a crude membrane fraction derived from rat renal cortex. The
isolation was performed by a⁄nity chromatography on concanavalin
A (ConA)-Sepharose [24], followed by immunoa⁄nity chromatogra-
phy on the monospeci¢c mAb 13.4 [25]. Elution was performed with
0.25 M K-methyl-mannopyranoside in TBS, pH 7.8 and 50 mM di-
ethylamine (pH gradient 10.5 to 11.5), respectively. This puri¢cation
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procedure yielded a pure protein preparation with a speci¢c enzymatic
activity of 45 U/mg and an enrichment factor of 160. The mAb 13.4
against DPP IV has been characterized previously [26].
2.2. Analysis of the immunopuri¢ed DPP IV preparation
Determination of DPP IV exopeptidase activity: The DPP IV exo-
peptidase activity was measured with the substrate Gly-Pro-4-nitro-
anilide-tosylate (Bachem, Heidelberg, Germany) as described before
[27]. DPP IV exopeptidase overlay assay: DPP IV samples were sub-
jected to SDS-PAGE, then transferred to nitrocellulose and incubated
with Gly-Pro-2-naphthylamide-HCl/Fast Garnet GBC salt mixture
(Bachem) as described by Walborg et al. [19]. Immunoblotting:
SDS-PAGE and protein transfer to nitrocellulose membranes were
performed according to standard protocols using a Mini-Protean II
system (BioRad, Muºnchen, Germany). The blots were developed with
mAb 13.4 against DPP IV.
2.3. Gelatin zymography
Gelatin zymography for the detection of gelatinase activity of DPP
IV was originally described by Heussen and Dowdle [28] and modi¢ed
by Chen et al. [29]. In our experiments, 7.5% SDS-polyacrylamide gels
were prepared containing copolymerized heat-denatured collagen type
I (SIGMA, Deisenhofen, Germany, C 8897) at a ¢nal concentration
of 0.5 mg/ml. The subsequent electrophoresis of puri¢ed DPP IV
samples mixed with reducing SDS-PAGE sample bu¡er was per-
formed at 4‡C and 100 V to preserve the native conformation of
DPP IV. The gels were washed with 2.5% Triton X-100 (v/v) twice
for 15 min each to remove SDS, which reversibly inhibits DPP IV
activity. They were then rinsed brie£y with TBS, pH 7.4, incubated in
TBS, 2.5 mM EDTA at 37‡C for 8 h and stained with Coomassie
Blue. Gelatinase activity was revealed by negative staining of trans-
parent bands. Mr markers appeared as darker bands in the gelatin
gels.
2.4. Soluble proteolytic assay
Twenty Wg acid-soluble, thermally denatured collagen were incu-
bated with 8 Wg active DPP IV at 37‡C in sterile TBS, 2.5 mM
EDTA, pH 7.4 for di¡erent periods of time. The proteolytic reaction
was stopped by boiling with reducing SDS-PAGE sample bu¡er. Ali-
quots of the mixtures were separated by SDS-PAGE and stained with
Coomassie Blue. In gels, collagen degradation was manifested as a
decrease in the intensity of the collagen bands. The K1-chain bands
were densitometrically quanti¢ed using an AGFA ARCUS II scanner
and IP Lab Gel H software. The detection limit was about 100 ng.
The amount of collagen detected at the beginning of the reaction was
de¢ned as 100%. Each value was calculated by the average of three
experiments. The coe⁄cient of variation (cv) was between 5% and
10% for all reported values.
For protease inhibitor pro¢le analysis of DPP IV endopeptidase
activity, speci¢c inhibitors were added to the soluble proteolytic assay
before incubation for 80 h. The concentrations used are listed in Table
1. Pepstatin, diprotin A and diprotin B were purchased from Bachem,
EDTA and SDS from Roth, Karlsruhe, Germany. Iodoacetamide,
leupeptin, NEM, 1,10-phenanthroline, DFP, PMSF, aprotinin and
DTT were obtained from SIGMA. Stock solutions of TPCK,
PMSF and phenanthroline were prepared in DMSO. At the concen-
trations used, DMSO has no e¡ect on the endo- or exopeptidase
activity of DPP IV.
For investigation of DPP IV endopeptidase substrate speci¢city,
denatured collagen of di¡erent types (SIGMA, C 8897, C 1188, C
4407, C 7521, C 3657) was used for the soluble proteolytic assay.
The incubation times were 5, 10, 20, 40, 60 and 80 h, respectively.
The reaction mixtures were compared with respective controls without
DPP IV incubated for the same period of time.
3. Results and discussion
In this paper we describe an endopeptidase activity of im-
munopuri¢ed DPP IV as demonstrated by the digestion of
heat-denatured ¢brillar collagens.
3.1. Isolation of DPP IV from rat kidney
To ensure homogeneity of our DPP IV preparation, we
puri¢ed the enzyme in two chromatographic steps. A solubil-
ized crude membrane fraction of rat renal cortex was submit-
ted to preparative ConA-Sepharose chromatography, fol-
lowed by immunoa⁄nity chromatography on the DPP IV-
speci¢c immobilized mAb 13.4. The immunopuri¢ed DPP
IV was analyzed by SDS-PAGE under non-denaturing reduc-
ing conditions, followed by silver stain, immunoblotting and
DPP IV exopeptidase overlay assay (Fig. 1). The 140 kDa
and 110 kDa band represent the active and inactive form of
the DPP IV monomer, respectively, as demonstrated by im-
munoblot analysis with mAb 13.4 and by exopeptidase over-
lay assay using the DPP IV-speci¢c substrate, Gly-Pro-2-
naphthylamide. Additionally, sometimes traces of the 290
kDa active dimeric form of DPP IV as well as a 60 kDa
protein appeared in the immunopuri¢ed DPP IV preparation.
N-terminal amino acid sequence analysis revealed that the
60 kDa protein represents a fragment of DPP IV starting at
amino acid 281 (Bermpohl and Weise, unpublished results),
con¢rming earlier observations [30].
3.2. Gelatin zymography
To directly demonstrate the endopeptidase activity of im-
munopuri¢ed DPP IV, a gelatin zymography assay was estab-
lished. DPP IV was separated under mild conditions in SDS-
polyacrylamide gels containing copolymerized heat-denatured
collagen. After electrophoresis gels were incubated at 37‡C for
8 h and stained with Coomassie Blue. To suppress any gela-
tinase activity of other proteases, 2.5 mM EDTA was added
to the incubation bu¡er. Gelatinase activity of separated pro-
teins should lead to a disintegration of the corresponding
gelatin matrix as revealed by a colorless, non-stained area in
the gel. As shown in Fig. 2A, the immunopuri¢ed DPP IV
fraction generated a clear 140 kDa area which corresponds to
the Mr of native DPP IV. The zone of proteolytic activity
became greater with increasing concentrations of DPP IV,
suggesting a speci¢c DPP IV-dependent proteolytic activity.
No further gelatin degrading activity became visible, which
argues for the homogeneity of our DPP IV preparation. The
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Fig. 1. Immunopuri¢cation of DPP IV monitored by SDS-PAGE.
Five Wg of the immunoa⁄nity chromatography eluate were sepa-
rated under non-denaturing reducing conditions, followed by silver
staining (lane 1), immunoblotting with mAb 13.4 (lane 2), or the
DPP IV exopeptidase overlay assay using Gly-Pro-2-naphthylamide/
Fast Garnet (lane 3).
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digestion of gelatin by DPP IV provides evidence for intra-
molecular cleavage sites and, thus, for the endopeptidase ac-
tivity of DPP IV. The presence of the Gly-X-Y motif in ¢-
brillar collagens means that removal of the ¢rst N-terminal
dipeptide would produce a peptide in which glycine is the
penultimate residue. Therefore the observed gelatin degrada-
tion could not have been the result of stepwise exopeptidase
digestion of the collagen chains by DPP IV. In addition, a
tripeptidase activity of DPP IV has been excluded [6].
3.3. Soluble proteolytic assay
To further characterize DPP IV endopeptidase activity a
soluble proteolytic assay was established, which allowed quan-
ti¢cation of gelatin degradation by densitometric scanning of
gels for the disappearance of K1-chain bands. For this pur-
pose, thermally denatured collagen was incubated with DPP
IV in the presence of 2.5 mM EDTA at 37‡C for di¡erent
periods of time, then separated by SDS-PAGE and stained
with Coomassie Blue. As shown in Fig. 2B, the amount of
detectable collagen gradually decreased during the period of
the investigation. We did not detect cleavage products in this
assay, but using anti-collagen antibodies we detected frag-
ments in immunoblots (data not shown). The detection of
only small amounts of cleavage products may be due to the
spreading of fragments over the gel.
3.3.1. In£uence of inhibitors on DPP IV endo- and exopep-
tidase activity. Using the soluble proteolytic assay, various
substances were investigated for their inhibitory in£uence on
DPP IV endopeptidase activity (Table 1). The results were
compared with the e¡ects of the same modulators on DPP
IV exopeptidase activity, as determined by the standard Gly-
Pro-p-nitroanilide assay. In summary, both the endo- and the
exopeptidase activities of DPP IV were inhibited by the serine
protease inhibitors DFP (0.6 mM) and PMSF (9 mM) as well
as by diprotin A (13 mM) and diprotin B (13 mM), which are
well characterized competitive inhibitors of DPP IV exopepti-
dase activity. However, neither the endo- nor the exopeptidase
activity of DPP IV was signi¢cantly in£uenced by aspartate-,
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Fig. 2. Endopeptidase activity of DPP IV. A: Gelatin zymography performed with di¡erent concentrations of immunopuri¢ed DPP IV.
B: Soluble proteolytic assay showing degradation of denatured collagen type II by DPP IV as a function of time.
Table 1
E¡ects of di¡erent types of protease inhibitors on DPP IV endo- and exopeptidase activity
Inhibitor (concentration) Endopeptidase activity Exopeptidase activity
Control 100.0% 100.0%
Aspartate-
Pepstatin (10 mg/ml) 95.8% 91.0%
Cysteine-
Iodoacetamide (10 mM) 101.9% 94.0%
Leupeptin (10 mg/ml) 88.8% 89.6%
N-ethylmaleimide (1 mM) 103.1% 87.4%
Metallo-
1,10-phenanthroline (6 mM) 70.7% 71.9%
Serine-
Diisopropyl £uorophosphate (0.6 mM) 10.8% 1.1%
PMSF (1 mM) 85.8% 84.4%
PMSF (9 mM) 14.2% 12.2%
DPP IV-speci¢c
Diprotin A (13 mM) 10.5% 14.3%
Diprotin B (13 mM) 38.6% 51.2%
Others
1% SDS (v/v) 0.1% 1.2%
TPCK (10 mM) 90.8% 102.9%
Aprotinin (10 mg/ml) 88.8% 88.5%
Dithiothreitol (3 mM) 51.6% 84.0%
Values of DPP IV endopeptidase activity were determined by the soluble proteolytic assay followed by densitometric gel scanning. To measure DPP
IV exopeptidase activity aliquots of the respective soluble proteolytic assays were applied to the Gly-Pro-2-nitroanilide assay after 1 h and 80 h of
incubation. The values of DPP IV exopeptidase activity listed in the table represent the mean of both measurements. The activity obtained from
DPP IV without protease inhibitor was de¢ned as 100%. The results shown are from three separate experiments.
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cysteine- and metalloprotease inhibitors. The only di¡erence
in response to an inhibitor was observed with 3 mM DTT,
which inhibited DPP IV endopeptidase activity but not the
exopeptidase activity. This can be explained by the reducing
properties of high concentrations of DTT, which might cleave
disul¢de bridges in the cysteine-rich region of DPP IV leading
to a conformational change of the enzyme, which presumably
a¡ects the collagen-binding property of DPP IV but not the
active site of its exopeptidase activity [17]. This conclusion is
in accordance with a study of Loºster et al., who identi¢ed the
cysteine-rich region of DPP IV as the collagen-binding site,
which does not contain the active site of DPP IV exopeptidase
activity itself [15]. Thus, apart from the response to DTT, the
endo- and exopeptidase activities of DPP IV showed the same
protease inhibitor pro¢le, including similar inhibition by DFP
and by diprotin A and B, which are speci¢c competitive in-
hibitors of DPP IV exopeptidase activity. We therefore sug-
gest that both the endo- and the exopeptidase activity of DPP
IV reside in a common active site. This conclusion is sup-
ported by the observation that the active site of the enzyme
is only labelled on ser624 by [32P]Dip-F [31].
3.3.2. Determination of substrate speci¢city. To determine
the substrate speci¢city of DPP IV endopeptidase activity, the
soluble proteolytic assay was performed with di¡erent poten-
tial substrates. Albumin and ¢bronectin were not digested by
DPP IV (data not shown), which, in view of the low incidence
of proline residues in these proteins, suggests that DPP IV
endopeptidase activity depends on the presence of a proline-
speci¢c cleavage site. This conclusion is supported by the in-
hibitory e¡ect of the proline-containing tripeptides, diprotin A
and B, on DPP IV endopeptidase activity. DPP IV also failed
to degrade native collagens (data not shown), although it
attacked denatured collagens, indicating the incapacity of
DPP IV to cleave triple-helical structures. Although all the
investigated types of denatured collagens were attacked by
the enzyme, they were not all cleaved at the same rate; K1-
chains of the ¢brillar collagen types I, II, III and V were
cleaved more rapidly than the K1-chains of basement mem-
brane collagen type IV (Fig. 3). These di¡erences in cleavage
speci¢city are probably due to di¡erent structural constraints
on the DPP IV molecule in its interaction with ¢brillar colla-
gen and basement-type collagen.
3.4. Physiological relevance of DPP IV endopeptidase activity
Compared with other gelatinases and collagenases and with
DPP IV exopeptidase activity, DPP IV exhibits weak endo-
peptidase activity. Only 20 Wg of denatured ¢brillar collagens
were digested by 8 Wg active DPP IV within 80 h, which
represents a very slow cleavage rate, even allowing that each
collagen molecule was cleaved at many sites in the chain.
Contamination with a matrix metalloprotease or a bacterial
collagenase should be excluded, since both are inhibited by
EDTA and by 1,10-phenanthroline [32,33] which did not in-
£uence the endopeptidase activity of DPP IV. Moreover, the
largest member of the matrix metalloprotease family is the
92 kDa type IV collagenase (gelatinase B) which was not
detected in the zymography [34].
This slow cleavage rate, together with the inability to cleave
native collagens, suggests that the biological relevance of DPP
IV endopeptidase activity should be seen in context with other
collagenases and gelatinases, as well as with DPP IV exopep-
tidase activity. Therefore DPP IV might participate in ¢nal
collagen degradation, which is generally initiated by intersti-
tial collagenases. Alternatively, DPP IV endopeptidase activ-
ity might have auxiliary functions in cell-matrix adhesion
processes by unmasking cryptic binding sites of collagen-like
RGD and DGEA sequences, thus making them accessible for
the integrin receptors K2/L1, K3/L1 and K5/L1 [35].
Recent analysis of the amino acid sequence of seprase
(FAPK), a gelatinolytic endopeptidase, which is localized in
melanoma, carcinoma and sarcoma cells revealed 68% amino
acid sequence identity to DPP IV in their catalytic regions and
a remarkably similar structural organization of both enzymes
[23]. Since a common gelatinolytic activity has now been de-
tected, we agree with Goldstein et al. in proposing that DPP
IV and seprase represent a new subfamily of gelatinolytic in-
tegral membrane serine proteases [23].
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